Johnston, PV, Duckers, HJ, Raval, AN, Cook, TD, Traverse, JH, Abraham, WT, Altman, PA, Pepine, CJ. The CardiAMPHeart Failure Trial: Efficacy Outcomes from Roll-In Phase. Presented at the Annual Scientific Sessions of the American Heart Association, November 12, 2018.
Johnston P, Duckers H, Raval A, Cook TD, Pepine CJ. Not all stem cells are created equal: The case for prospective assessment of stem cell potency in the CardiAMP Heart Failure Trial. Circ Res 2018;123:944–46.
Johnston PV, Duckers HJ, Raval AN, Cook T, Traverse JH, Abraham WT, Altman PA, Pepine CJ. The CardiAMP™ Heart Failure Clinical Trial First Results from the Unblinded Roll-In Phase. Presented at the Annual Meeting of Transcatheter Cardiovascular Therapeutics, September 24, 2018.
Duckers, HJ, Ravel AN, Pepine, CJ, Johnston, PV, Traverse JH, Emery, J, Miller, L, Abraham, WT, Altman, PA. Performance of Helix transendocardial biotherapeutic delivery system after 300 cases. Presented at the Annual Meeting of Transcatheter Cardiovascular Therapeutics, September 24, 2018.
Pepine, CJ, Raval, AN, Johnston, PV, Traverse, JH, Abraham, WT, Altman, PA. CardiAMP™ Heart Failure Trial Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using CardiAMP Cell Therapy System in Patients with Post Myocardial Infarction Heart Failure. Presented at Annual Meeting of Heart Failure Society of America. September 15-18, 2018.
Raval AN, Cook TD, Duckers HJ, Johnston PV, Traverse JH, Abraham WT, Altman PA, Pepine CJ. The CardiAMP Heart Failure trial: A randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post–myocardial infarction heart failure: Trial rationale and study design, American Heart Journal, (In Press) April 2018.
Bergmann MW, Heeger C, Jaquet K, Boosfeld C et al. Early Transendocardial Autologous Bone Marrow Injection Of Bone Marrow Derived Mononuclear Cells Following Ischemic Myocardial Events (the Alster - Helix Phase I Study), CRT 2016.
Wong Po Foo C, Rouy D, Hare JM, et al. The transendocardial autologous cells in ischemic heart failure trial bone marrow mononuclear cells (TAC-HFT-BMC) randomized placebo controlled blinded study, Regenerative Medicine 2015, 10(7s), S169.
Hare JM, Fishman, JE, Gerstenblith G, et al. Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy, The POSEIDON Randomized Trial, JAMA. 2012;308(22).
The Big Biz show
University of Minnesota
BioWorld Med Tech
BioWorld Med Tech
CALL US NOW
EMAIL US NOW